Publication | Closed Access
Exagamglogene Autotemcel for Severe Sickle Cell Disease
304
Citations
13
References
2024
Year
Treatment with exa-cel eliminated vaso-occlusive crises in 97% of patients with sickle cell disease for a period of 12 months or more. (CLIMB SCD-121; ClinicalTrials.gov number, NCT03745287.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1